This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Decode Genetics Ehf. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Thorunn Rafnar
Introduction
Thorunn Rafnar is a prominent inventor based in Reykjavik, Iceland. She has made significant contributions to the field of genetics, particularly in relation to lung cancer. Her work focuses on identifying genetic variants that can serve as susceptibility markers for this disease.
Latest Patents
Thorunn Rafnar holds a patent titled "Susceptibility variants for lung cancer." This invention discloses certain genetic variants as susceptibility variants for lung cancer. The invention relates to methods of risk assessment using such variants. Additionally, it includes kits designed for use in the risk assessment of lung cancer.
Career Highlights
Thorunn Rafnar is associated with Decode Genetics Ehf, a company known for its groundbreaking work in genetic research. Her role at the company has allowed her to contribute to important advancements in understanding genetic predispositions to diseases.
Collaborations
Thorunn has collaborated with notable colleagues, including Thorgeir E Thorgeirsson and Patrick Sulem. These collaborations have further enhanced her research and the impact of her inventions.
Conclusion
Thorunn Rafnar's innovative work in identifying genetic variants related to lung cancer showcases her dedication to advancing medical science. Her contributions are vital in the ongoing efforts to improve risk assessment and treatment options for lung cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile